NCF2 and cancer: There is evidence that NCF2 can be used as a key gene for AS [41], which is also associated with a variety of diseases and acts as a negative factor in diseases including cancer, leukaemia [42], myocardial infarction [43], systemic lupus erythematosus [44] and so on.